| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Chimera Investment (NYSE:CIM) reported quarterly earnings of $0.37 per share which missed the analyst consensus estimate of $0....
Chimera Investment (NYSE:CIM) reported quarterly earnings of $0.39 per share which missed the analyst consensus estimate of $0....
UBS analyst Douglas Harter maintains Chimera Investment (NYSE:CIM) with a Buy and raises the price target from $15 to $16.
Keefe, Bruyette & Woods analyst Bose George maintains Chimera Investment (NYSE:CIM) with a Market Perform and lowers the...